Abstract
We have recently found that diethylstilbestrol (DES), a synthetic estrogen agonist, inhibits thrombin-induced Ca2+ influx in human platelets, but it remains unclear to what extend this effect might be related to the store-operated Ca2+ influx pathway. To study the effect of DES on store-operated channels and capacitative Ca2+ influx, we used rat basophilic leukemia (RBL) cells, vascular smooth muscle cells (SMC), and human platelets, and recorded whole-cell Ca2+ release-activated Ca2+ (CRAC) currents and thapsigargin (TG)-induced capacitative Ca2+ influx. In this study, we demonstrate that extracellular DES produces a dose-dependent and reversible inhibition of CRAC currents in RBL cells (IC50, ∼0.5 μM), whereas intracellular DES (25 μM) has no effect. Extracellular DES (up to 30 μM) inhibited only CRAC but did not affect a whole-cell monovalent cation current mediated by TRPM7 channels. DES effectively inhibited TG-induced capacitative Ca2+ influx in a dose-dependent manner with an IC50 values of ∼0.1 μM in RBL cells, <0.1 μM in SMC, and ∼1 μM in human platelets. It is noteworthy that trans-stilbene, a close structural analog of DES that lacks hydroxyl and ethyl groups, had no effect on CRAC current and on store-operated Ca2+ influx. Thus, we found DES to be a very effective inhibitor of store-operated channels and Ca2+ influx in a variety of cell types.
- Received January 22, 2004.
- Accepted June 16, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|